This enrolling by invitation study focuses on depression and currently lists sites or participation links in United States.
This study exists to understand how the medication BHV-7000 holds up over time after the earliest research stage. For people living with Depression, that matters because care needs to work in daily life, not just in theory. The findings could guide better understanding and future care, and taking part helps build that evidence for others.
The official record suggests in-person participation through a lab, with sites including Reverie Mind, LLC in Chandler, IMA Clinical Research in Phoenix, and Pillar Clinical Research, LLC in Little Rock. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually having a stable enough treatment background for the study and being able to follow the planned visits or tasks, while common reasons not to take part include safety concerns that need urgent care first and major medical issues that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordTaking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in United States.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com